Animal Health Vaccine Development Summit on January 31-February 01, 2024 in Kansas City, United States

Emerging advances in biopharma development and manufacturing processes are rapidly changing the game for animal health drug development. As this community capitalizes on advanced platform technologies, RNA vaccines and other innovations, this year alone has seen the first-ever vaccine for honeybees – medicines for animal health are on the cusp of something truly exciting.

With increased investment, collaboration, and more promising innovation than ever before, the Animal Health Vaccine Development Summit has been curated as the industry's first R AND D-centred forum dedicated solely to showcasing the latest advances in high-value vaccine technologies being harnessed for intervention against infectious disease, cancer and chronic pain, from biopharma and academia. As we navigate through the progressive science in animal health, this forum will arm the community with the means to discover, design, and develop the next generation of veterinary medicines.

URLs:

Tickets: https://go.evvnt.com/1970722-2?pid=10008

Brochure: https://go.evvnt.com/1970722-3?pid=10008

Time: 8:00 AM - 5:00 PM

Prices:

Drug Developer Conference Ticket: USD 2599.00,

Academic and Not-for-Profit Conference Ticket: USD 2199.00,

Solution and Service Provider Conference Ticket: USD 3299.00

Speakers: Aemro Kassa, Senior Scientist, Vaccines Boehringer Ingelheim, Arvind Kumar, Vice President, Research BiomEdit, Fatou Sow, Head of Immunology Research, Non Infectious Diseases Boehringer Ingelheim, Ferdinando Neilson de Almeida, Director, R AND D Ourofino Animal Health, Hussein Ahmed, Director of Scientific Office Klybeck Life Sciences, Joshua Elston, Diagnostics Team Leader, Molecular Vaxxinova, Kurt Kamrud, Director of Genomic Platforms Ceva Animal Health, Mahmoud Samir, Head of R AND D Department Vaccine Valley, Mark Mogler, Principal Scientist Merck Animal Health, Manuel Borca, Lead Scientist, Agricultural Research Service, USDA, Richard Sibbel, Strategic and Technical Lead Mazen Animal Health, Ron Cravens, Chief Medical Officer MBF Therapeutics, Senta Walton, Head of R AND D Saiba Animal Health, Sherry Layton, Chief Executive Officer Vetanco, USA, Steven Witte, Director Biologics Development Module Agricultural Research Service, USDA, Tammie Wahaus, Chief Executive Officer ELIAS Animal Health, Tracy Raines, Vice President R AND D Mazen Animal Health